IDIDFC MFDirect · Growth

Bandhan Healthcare Fund - Growth - Direct Plan

Pharma & Health CareEquity - Sectoral Fund - Pharma & Health CareBenchmark: BSE Health Care - TRI
NAV · 15 Sep 2026₹11.27-1.42%
AUM₹332 Crfrom this fund's primary plan
Expense Ratio1.22%
CAGR
Exit Load0.50% on or before 30D, Nil after 30D
Min SIP₹100from this fund's primary plan
Launched2025

Investment Objective

The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.

Fund Mandate

Debt Securities and Money Market Instruments (including G-Sec, Securitised debt)0%–20%
Equity & Equity related securities other than above and overseas securities0%–20%
Equity & equity related instruments engaged in Healthcare, Pharma and Allied sectors80%–100%
Units issued by REITs & InvITs0%–10%
Fund Managers
VK
Viraj Kulkarni
Fund Manager
Key Information
1.22%
₹100from this fund's primary plan
₹1,000
0.50% on or before 30D, Nil after 30D
Nil
Inception28 Nov 2025
AMCIDFC MF
Top Holdings

Portfolio holdings not disclosed for this fund yet.

Trailing Returns
PeriodReturnsCategory avg
1 Day-1.42%
1 Week-1.53%-2.62%
1 Month-0.88%-4.01%
3 Months+8.83%+0.58%
6 Months+18.16%+9.14%
9 Months+14.25%+1.98%
+12.68%+16.23%

Category avg is the average return of every scheme in this fund's SEBI class (Equity - Sectoral Fund - Pharma & Health Care) over the same period. Returns up to 1 year are absolute; returns beyond 1 year are annualised (CAGR). This is Accord's own stated convention for equity-oriented schemes.

Risk Metrics
16.08%

A measure of how much a fund's returns swing up and down over time. Higher means a bumpier ride — more volatility — even if the average return ends up the same as a steadier fund.

0.55

How sensitive a fund is to overall market moves. A beta of 1 means it roughly moves in line with the market; below 1 means smaller swings than the market; above 1 means bigger swings in both directions.

-0.57

How much extra return a fund earned for every unit of risk (volatility) it took on, compared to a safe, risk-free investment. Higher means better risk-adjusted performance — not just higher returns, but smarter ones.

5.62%

The extra return a fund generated above what its benchmark index would predict, given the risk it took. Positive alpha suggests the fund manager added genuine value beyond just tracking the market.

-1.13

Similar to the Sharpe Ratio, but only counts downside volatility (the bad kind) rather than penalizing a fund for volatile-but-positive swings. Higher means better returns per unit of "harmful" risk.

-7.27%

The single worst peak-to-trough fall a fund has experienced over a given period — the deepest "how much would I have lost if I'd bought at the top and sold at the bottom" scenario.

Fees
1.22%
0.50% on or before 30D, Nil after 30D
Nil
₹100from this fund's primary plan
₹1,000
Capital Gains Tax, general rules

This is an equity-oriented fund. Under rules effective since Budget 2024 (23 July 2024):

Short-Term Capital Gains (held ≤ 12 months): taxed at a flat 20%.

Long-Term Capital Gains (held > 12 months): taxed at 12.5% on gains above ₹1.25 lakh in a financial year, with no indexation benefit.

General information only, not tax advice, actual liability depends on your overall income and applicable law at the time of redemption. Consult a tax advisor for your specific situation.

Frequently Asked QuestionsGeneral mutual-fund FAQs, not specific to this scheme